188 related articles for article (PubMed ID: 32875515)
21. Droplet Digital PCR for
Bochicchio MT; Petiti J; Berchialla P; Izzo B; Giugliano E; Ottaviani E; Errichiello S; Rege-Cambrin G; Venturi C; Luciano L; Daraio F; Calistri D; Rosti G; Saglio G; Martinelli G; Pane F; Cilloni D; Gottardi EM; Fava C
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771634
[No Abstract] [Full Text] [Related]
22. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.
Zagaria A; Anelli L; Coccaro N; Tota G; Casieri P; Cellamare A; Impera L; Brunetti C; Minervini A; Minervini CF; Delia M; Cumbo C; Orsini P; Specchia G; Albano F
Virchows Arch; 2015 Sep; 467(3):357-63. PubMed ID: 26149409
[TBL] [Abstract][Full Text] [Related]
23. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
Griffiths M; Patton SJ; Grossi A; Clark J; Paz MF; Labourier E;
Arch Pathol Lab Med; 2015 Apr; 139(4):522-9. PubMed ID: 25061833
[TBL] [Abstract][Full Text] [Related]
24. Molecular Monitoring of Chronic Myeloid Leukemia.
Dominy K; Mokretar K; Reid AG; Khorashad JS
Methods Mol Biol; 2020; 2065():153-173. PubMed ID: 31578694
[TBL] [Abstract][Full Text] [Related]
25. Committed change of real-time quantitative PCR to droplet digital PCR for monitoring
Kongruang A; Limsuwanachot N; Magmuang S; Areesirisuk P; Niparuck P; Siriboonpiputtana T; Rerkamnuaychoke B
Hematology; 2023 Dec; 28(1):2256199. PubMed ID: 37695125
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of BCR::ABL (P210) mRNA levels detected by dPCR and qPCR methods in patients with chronic myeloid leukemia].
Gao HL; Hao Y; Chen WM; Li LD; Wang X; Qin YZ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):906-910. PubMed ID: 38185519
[No Abstract] [Full Text] [Related]
27. Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study.
Park H; Shin DY; Kim I; Sohn SK; Koh Y; Lee JH; Lee KH; Kim DY; Kim HJ; Ahn JS; Lee JO; Bang SM; Cheong JW; Park SG; Park S; Lee YJ; Ahn SY
In Vivo; 2019; 33(6):2273-2280. PubMed ID: 31662567
[TBL] [Abstract][Full Text] [Related]
28. Absolute quantification of BCR-ABL1 fusion transcripts in pediatric chronic myeloid leukemia.
Tang Y; Wei X; Chen J; Du Y; Chu H; Mao L; Chen J; Xu Q; Tang J; Shen S; Mao M
Leuk Lymphoma; 2016 Sep; 57(9):2216-8. PubMed ID: 27095369
[No Abstract] [Full Text] [Related]
29. Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remission.
Lu L; Kok CH; Dang P; Branford S; Saunders VA; Shanmuganathan N; Ross DM; Hughes TP; Yeung DTO
Br J Haematol; 2022 Aug; 198(3):600-603. PubMed ID: 35620965
[No Abstract] [Full Text] [Related]
30. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
Koren-Michowitz M; Shimoni A; Daraio F; Crasto F; Lorenzatti R; Volchek Y; Amariglio N; Gottardi E; Saglio G; Nagler A
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1852-5. PubMed ID: 26151304
[TBL] [Abstract][Full Text] [Related]
31. Comparison of molecular responses based on BCR-ABL1% (IS) results from an in-house TaqMan-based qPCR versus Xpert(®) assay in CML patients on tyrosine kinase inhibitor therapy.
Boeckx N; Laer CV; Roover JD; Wilmsen B; Bruyninckx K; Pauwels S
Acta Clin Belg; 2015 Aug; 70(4):237-43. PubMed ID: 26166681
[TBL] [Abstract][Full Text] [Related]
32. Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.
Bernardi S; Malagola M; Zanaglio C; Polverelli N; Dereli Eke E; D'Adda M; Farina M; Bucelli C; Scaffidi L; Toffoletti E; Deambrogi C; Stagno F; Bergamaschi M; Franceschini L; Abruzzese E; Divona MD; Gobbi M; Di Raimondo F; Gaidano G; Tiribelli M; Bonifacio M; Cattaneo C; Iurlo A; Russo D
Cancer Med; 2019 May; 8(5):2041-2055. PubMed ID: 30950237
[TBL] [Abstract][Full Text] [Related]
33. Molecular monitoring 101: helping your patients with chronic myeloid leukemia to understand the meaning of molecular response.
Jabbour EJ; Quintás-Cardama A
Leuk Lymphoma; 2012 Aug; 53(8):1452-60. PubMed ID: 22273251
[TBL] [Abstract][Full Text] [Related]
34. Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme.
Scott S; Travis D; Whitby L; Bainbridge J; Cross NCP; Barnett D
Br J Haematol; 2017 May; 177(3):414-422. PubMed ID: 28295199
[TBL] [Abstract][Full Text] [Related]
35. [Molecular analysis of the BCR-ABL1 fusion gene in a chronic myeloid leukemia patient with BCR-ABL1 International Scale-undetectable disease].
Kawamata N; Watanabe R
Rinsho Ketsueki; 2019; 60(7):767-772. PubMed ID: 31391364
[TBL] [Abstract][Full Text] [Related]
36. Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.
McCarron SL; Langabeer SE; Bolger K; Haslam K; Crampe M; Kelly J; Morrell R
Med Oncol; 2015 Feb; 32(2):452. PubMed ID: 25579165
[TBL] [Abstract][Full Text] [Related]
37. Optimized Digital Droplet PCR for BCR-ABL.
Maier J; Lange T; Cross M; Wildenberger K; Niederwieser D; Franke GN
J Mol Diagn; 2019 Jan; 21(1):27-37. PubMed ID: 30347270
[TBL] [Abstract][Full Text] [Related]
38. A review of the challenge in measuring and standardizing BCR-ABL1.
Yu S; Cui M; He X; Jing R; Wang H
Clin Chem Lab Med; 2017 Aug; 55(10):1465-1473. PubMed ID: 28222016
[TBL] [Abstract][Full Text] [Related]
39. Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia.
Gerrard G; Foong HE; Mudge K; Alikian M; Apperley JF; Foroni L
Leuk Res; 2016 Oct; 49():47-50. PubMed ID: 27552679
[TBL] [Abstract][Full Text] [Related]
40. A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.
García-Gutiérrez V; Gómez-Casares MT; Puerta JM; Alonso-Domínguez JM; Osorio S; Hernández-Boluda JC; Collado R; Ramírez MJ; Ibáñez F; Martín ML; Rodríguez-Gambarte JD; Martínez-Laperche C; Gómez M; Fiallo DV; Redondo S; Rodríguez A; Ruiz-Nuño C; Steegmann JL; Jiménez-Velasco A;
PLoS One; 2017; 12(3):e0173532. PubMed ID: 28278193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
